Literature DB >> 455778

DNA binding activity of serum from patients with systemic lupus erythematosus.

J F Halsey, W A Woolery, S Oleinick, M B Kahaleh, E C Leroy.   

Abstract

The reaction conditions essential for reproducible use of the cellulose ester membrane filter assay for anti-DNA antibody levels in patients with systemic lupus erythematosus are described. A dependence of DNA-binding capacity on serum concentration was observed in the assay, requiring that serum concentrations be comparable in determinations of DNA-binding activity of different sera and when comparing different published studies. The DNA-binding capacity of serum from lupus patients was found to be significantly different from that of healthy controls. However, the binding capacities were not significantly different between lupus patients with and without nephritis. The relative avidity of the anti-DNA antibodies were estimated from plots of 1/DNA bound vs 1/DNA free and these data indicate that the avidities of the antibodies from the two groups of lupus patients are not significantly different. This observation suggests that the tightness of binding between the DNA and the serum anti-DNA antibodies cannot be used to predict immune complex-induced nephritis in lupus patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455778      PMCID: PMC1537628     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  A comparative study of technics for the detection of antibodies to native deoxyribonucleic acid.

Authors:  P Davis; A S Russell; J S Percy
Journal:  Am J Clin Pathol       Date:  1977-04       Impact factor: 2.493

2.  Precipitating antibody to D.N.A. detected by two-stage electroimmunodiffusion. Study in S.L.E. and in rheumatoid arthritis.

Authors:  G D Johnson; J P Edmonds; E J Holborow
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

3.  Serum DNA binding activity in healthy subjects and in rheumatic disease.

Authors:  P Hasselbacher; E C LeRoy
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

4.  Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice.

Authors:  B H Hahn; M K Bagby; T R Hamilton; C K Osterland
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

5.  In vitro and in vivo cytotoxicity to EL-4 sarcoma in New Zealand mice.

Authors:  M E Gershwin; R J Klingenstein; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus.

Authors:  F Tron; J F Bach
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

7.  Evidence for the genetic control of antibody affinity from breeding studies with inbred mouse strains producing high and low affinity antibody.

Authors:  M W Steward; R E Petty
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

8.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

9.  Avidity of antibodies in SLE: relation to severity of renal involvement.

Authors:  S A Leon; A Green; G E Ehrlich; M Poland; B Shapiro
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb
View more
  5 in total

1.  Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; M Leirisalo; E Johansson; G Gripenberg
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

2.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.

Authors:  N I Abdou; H Wall; H B Lindsley; J F Halsey; T Suzuki
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

Review 3.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

4.  Circulating DNA-antibodies in systemic lupus erythematosus.

Authors:  T Helve; A M Teppo; P Kurki; O Wegelius
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

5.  Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma).

Authors:  M E Gershwin; H Abplanalp; J J Castles; R M Ikeda; J van der Water; J Eklund; D Haynes
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.